News

Important Update for TELUS International Investors: Class Action

Important Update for TELUS International Investors: Class Action

Significant Developments for TELUS International Investors

Faruqi & Faruqi, LLP, a leading national securities law firm, is taking a proactive approach in assisting investors impacted by recent developments at TELUS International (NYSE: TIXT). If you've incurred losses exceeding $50,000 in TELUS International, it’s crucial to understand your legal rights and options moving forward.

For those affected, Faruqi & Faruqi partner Josh Wilson invites you to reach out directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for a consultation.

Class Action Lawsuit Overview

The firm is currently investigating potential claims against TELUS International due to a federal securities class action that alleges violations of federal laws. The case emphasizes the need for investors to act swiftly, with a deadline of March 31, 2025 for those interested in becoming lead plaintiffs.

Investors’ Rights and Legal Options

The lead plaintiff serves a vital role by directing the litigation process on behalf of the affected investors. All class members have the option to motion for lead plaintiff status through their counsel, or they may choose to remain as absent class members.

Latest Financial Developments from TELUS International

Recently, TELUS International experienced a troubling financial quarter, reporting a significant decline in revenue compared to previous years. This shaky performance relates to the company's push towards artificial intelligence technologies, raising concerns regarding profitability and margin sustainability. The figures revealed a staggering $29 million drop in year-over-year revenue during the first quarter of 2024. Analysts noted increased pressure on company profits linked to this strategic transition.

Major Financial Setbacks

On May 9, 2024, TELUS International's first-quarter results shocked stakeholders, particularly when the Chief Financial Officer, Gopi Chande, stated that the margins from their AI offerings were “a bit below average.” This revelation resulted in a drastic share price drop of $1.41 or 18.15% on the same day, indicating deepening investor concerns.

Further compounding these challenges, the second quarter of 2024 saw the company unveil a continued downturn, reporting a $15 million year-over-year revenue decrease due to various operational pressures.

Implications for Shareholders

In light of these developments, shareholders need to stay informed about the ongoing legal proceedings. The court’s decision regarding the lead plaintiff will be pivotal, as it shapes the representation and potential recovery for affected investors. Whether or not you choose to become directly involved in the litigation does not impact your potential recovery outcome.

Get Involved

Faruqi & Faruqi encourages not only affected investors but also anyone with relevant information concerning TELUS International’s operations to come forward. Whistleblowers, former employees, and stakeholders can play a crucial role in shedding light on the practices surrounding the company.

For more details on the TELUS International class action and how you can participate, visit www.faruqilaw.com/TIXT or contact Josh Wilson at the numbers listed above for personal assistance.

Frequently Asked Questions

What is the class action lawsuit against TELUS International about?

The class action lawsuit centers around allegations of misleading statements and operational practices by TELUS International that have led to financial losses for investors.

Who can participate in this class action lawsuit?

Any investor who suffered losses exceeding $50,000 in TELUS International can participate, with the option to apply to become a lead plaintiff.

What is the deadline to act in this lawsuit?

The deadline to move for lead plaintiff status in the class action lawsuit is March 31, 2025.

How can I get more information?

Interested investors are encouraged to contact Faruqi & Faruqi or visit their official website for additional information regarding the class action.

What happens if I don’t become a lead plaintiff?

Your ability to share in any recovery is not affected by your decision to apply for lead plaintiff status; you may still recover as a class member.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Global Mayors Dialogue 2026: Ningbo Leads in Urban Ideas

Updated Category News Views 153

New Waves in City Collaboration Get this: from November 2 to 5, Ningbo, a key city nestled in east China's Zhejiang Province, is rolling out the red carpet for the 2026 Global Mayors Dialogue. Nearly 200 influential figures zooming into this seaside city isn't just for some aimless chit-chat. At the core, the theme is "Openness and Connectivity for Shared Opportunities."...

Continue Reading
Check Point Q3 2026 Results: Subtle Shifts or a Turning Point?

Updated Category News Views 176

Digging Deeper into Check Point's Latest Figures When Check Point Software Technologies Ltd. (NASDAQ:CHKP) throws numbers at the wall, not everything sticks, but there's always something telling. The Q3 financial results for 2026 are out, and it's a mixed bag—coffee’s getting cold before you parse through it. Revenue and Subscription Dynamics Let's cut to it: total...

Continue Reading
Platinum Equity's Bold Move on Warren Valve: An Analysis

Updated Category News Views 51

A Big Play in the Valve Game Straight out of the industrial playbook, Platinum Equity swoops in with its latest acquisition of Warren Valve, yanking it from the clutches of Allied Group. It's not every day you see a move like this in the flow control world. Yeah, you heard that right—flow control. The kind of business that’s all about ensuring the right stuff gets to...

Continue Reading
Pak Mail Jonesboro Dominates at Annex Brands Convention

Updated Category News Views 44

Small Town, Big Impact at the Annex Brands Shindig From little Jonesboro, Arkansas, comes a thunderous clap for the Kincades, who bagged a bunch of trophies and accolades at the big 2026 Annex Brands National Convention. Tim and Rhonda Kincade, the ones running Pak Mail Jonesboro, didn't just show up—they brought home the bacon with honors piled as high as the Ozarks....

Continue Reading
Anthropic's IPO Spurs Leverage Shares' New ETFs

Updated Category News Views 51

Taking a Gamble on AI's New Kid on the Block Here we stand on the edge of another potential AI stock bonanza. Anthropic’s got its sights set on going public, and folks are lining up to bite into what could be the next big generative AI feast. But it's Leverage Shares by Themes that's setting the scene for something a bit wilder—introducing some juicy leveraged and...

Continue Reading
Paulex Bio's PAL-119 Trials: A New Diabetes Frontier

Updated Category News Views 80

Chasing the Holy Grail in Diabetes Treatment The pursuit of a true remedy for diabetes is almost like hunting for the mythical beast—a challenge that's left plenty of contenders biting the dust over the years. Yet, here's Paulex Bio jumping right into the fray with their groundbreaking PAL-119. They're not just peddling another temporary fix like most on the market;...

Continue Reading
CodeBoxx CrewKit Forge: Decentralizing AI Development

Updated Category News Views 71

Unboxing the Machine: CodeBoxx's Ambitious Move When you're talking about shakin' up the tech world, look no further than CodeBoxx and their CrewKit Forge. Unveiled at the Titan 100 Tampa Bay gala, this AI software factory is a beast—a one-meter cube ready to replace a battalion of developers. Imagine not the sterile data centers but this thing chilling in your office,...

Continue Reading
Abracon Unveils Engineer-Focused Website Features

Updated Category News Views 59

Pushing the Needle in Digital Engagement Some days, the market talk brews hotter than a Texas barbecue, and today it’s Abracon serving up something new. They're tossing engineers a fresh digital bone with revamped website accounts. No bells or whistles, just a clean shot at making techies' lives easier as they tinker and design. It's a world where getting your hands on...

Continue Reading
Virginia Innovation Boosts Startups and Research Growth

Updated Category News Views 132

Virginia's Rising Innovation Ecosystem Virginia, a place you might not expect to hear much about in terms of innovation, is actually shaking things up and making waves on a national scale. Throwing their hat into the innovation arena, Virginia's landed itself a cozy #5 spot for its 'Innovation and Research Ecosystem,' according to Area Development's latest rankings. The...

Continue Reading
Restorative Getaways Aid Grieving Families, Offers Relief

Updated Category News Views 58

Finding Solace in Change: The Power of Stepping Away Grieving a lost child. It’s a trip to hell and back, and for many families, the journey feels endless. The press of everyday life—bills, jobs, commutes—offers no mercy. At times, stepping out of the blur might be the prime move toward healing, and that's where restorative getaways step in. Escaping the Everyday...

Continue Reading

Top 5 Most Recently Viewed Articles

Exousia Bio Advances Cancer Therapy with New Acquisition

Updated Category News Views 181

Exousia Bio Completes Strategic Acquisition In a significant move for the oncology sector, LAMY announced that it has finalized the acquisition of Exousia AI, Inc., expanding its prowess in exosome-based cancer therapies. This strategic maneuver, which involved the issuance of 62,223,000 shares of common stock, positions the company to leverage a promising preclinical...

Continue Reading
Getaround's Strategic Focus Shift: A Closer Look at Operations

Updated Category News Views 554

Getaround's Strategic Decision to Wind Down U.S. Operations Getaround, Inc., a notable player in the global car-sharing landscape, has made the tough decision to initiate an organized wind-down of its United States business operations. This strategic move will encompass both its car-share services and the HyreCar division, while continuing to strengthen and expand its...

Continue Reading
Pharmacists Mutual Insurance Company Transforms Into Group Structure

Updated Category News Views 294

Exciting Developments for Pharmacists Mutual Insurance Company Pharmacists Mutual Insurance Company, known for its leadership in commercial property and casualty insurance, is embarking on a significant transformation aimed at enhancing its service offerings and operational flexibility. The company is thrilled to announce its restructuring into a limited mutual holding...

Continue Reading
Winsome Resources Advances with Adina Lithium Project Permit Filing

Updated Category News Views 257

Winsome Resources Takes Step Forward with Adina Project Winsome Resources, a company dedicated to lithium exploration and development, proudly announces the submission of the Preliminary Information Statement for its Adina Lithium Project. This pivotal step has been taken in collaboration with the relevant authorities, marking the beginning of a refined provincial...

Continue Reading
Hoth Therapeutics Pioneers Drug-Induced Rash Treatment Solutions

Updated Category News Views 188

Hoth Therapeutics Innovates with HT-001 for Patient Care Hoth Therapeutics is making significant strides in oncology with its innovative drug HT-001, meticulously developed to ease dermatological side effects associated with MENIN inhibitors, a class of oncology drugs gaining traction in treating acute leukemias and specific solid tumors. The aim is to allow patients to...

Continue Reading